यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

roche registration gmbh - mosunetuzumab - eitilæxli, follicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - mergæxli - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - mergæxli - Æxlishemjandi lyf - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - Önnur lyf í taugakerfinu - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

prothya biosolutions netherlands b.v. - immunoglobulinum humanum inn - innrennslislyf, lausn - 50 mg/ml

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

atnahs pharma netherlands b.v. - ketorolacum trómetamól - stungulyf, lausn - 30 mg/ml

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

janssen-cilag international n.v. - talquetamab - mergæxli - Æxlishemjandi lyf - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

sanquin plasma products b.v. - storkuþáttur ix hjá mönnum - hemophilia b - antihemorrhagics, - meðferð og fyrirbyggja blæðingar í sjúklinga með dreyrasýki b (meðfædda þáttur laga skort).

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - benzydaminum hýdróklóríð; cetylpyridinii chloridum - munnholsúði, lausn - 1,5 mg/ml+5 mg/ml